Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Total Current Liabilities (2016 - 2026)

Heron Therapeutics filings provide 16 years of Total Current Liabilities readings, the most recent being $90.5 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 2.21% to $90.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $90.5 million, a 2.21% increase, with the full-year FY2025 number at $96.1 million, up 5.07% from a year prior.
  • Total Current Liabilities hit $90.5 million in Q1 2026 for Heron Therapeutics, down from $96.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $258.6 million in Q2 2025 to a low of $75.4 million in Q1 2024.
  • Median Total Current Liabilities over the past 5 years was $88.6 million (2025), compared with a mean of $97.6 million.
  • Biggest five-year swings in Total Current Liabilities: decreased 20.8% in 2023 and later soared 221.98% in 2025.
  • Heron Therapeutics' Total Current Liabilities stood at $82.4 million in 2022, then decreased by 3.24% to $79.7 million in 2023, then increased by 14.77% to $91.5 million in 2024, then grew by 5.07% to $96.1 million in 2025, then decreased by 5.81% to $90.5 million in 2026.
  • The last three reported values for Total Current Liabilities were $90.5 million (Q1 2026), $96.1 million (Q4 2025), and $89.7 million (Q3 2025) per Business Quant data.